Enzalutamide prostate cancer drug. This new hormone therapy drug, developed by Medivation and marketed by Astellas, was approved for use in the USA in
Enzalutamide prostate cancer drug. This new hormone therapy drug, developed by Medivation and marketed by Astellas, was approved for use in the USA in 2012. It has also been licensed for use in the UK. It is used in cases of advanced prostate cancer that are no longer responding to standard hormone therapy or chemotherapy.
Size: 5125px × 3411px
Photo credit: © DR P. MARAZZI/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: 2013, 21st, 40, adult, advanced, astellas, braille, brand, brandname, cancer, capsules, caucasian, century, clinic, display, displaying, doctor, dots, drug, enzalutamide, hands, healthcare, hold, holding, hospital, human, male, man, mdv3100, medical, medicine, mg, milligram, oncological, oncologist, oncology, oral, packaging, packet, people, person, pharmaceutical, pharmaceutics, pharmacological, pharmacology, physician, prostate, soft, treatment, white, xtandi
